Information Journal Paper
APA:
Copy. (2019). Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim. JOURNAL OF MEDICAL CHEMISTRY, 62(6), 2938-2949. SID. https://sid.ir/paper/1027743/en
Vancouver:
Copy. Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim. JOURNAL OF MEDICAL CHEMISTRY[Internet]. 2019;62(6):2938-2949. Available from: https://sid.ir/paper/1027743/en
IEEE:
Copy, “Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim,” JOURNAL OF MEDICAL CHEMISTRY, vol. 62, no. 6, pp. 2938–2949, 2019, [Online]. Available: https://sid.ir/paper/1027743/en